多学科德尔菲研究验证了在斯里兰卡情况下计算药物错误成本的变量
Sakunika Ranasinghe1, Dewmini Navodya1, Abarna Nadeshkumar1
1Phamacy and Pharmaceutical Sciences, University of Sri Jayewardenepura, Nugegoda, Sri Lanka.
BMJ open quality
|October 7, 2025
概括
为计算斯里兰卡的药物错误成本,制定了一份由八个成本变量组成的标准清单和指导方针. 通过医院账单分析确认了可访问性,解决了药物错误成本的关键差距.
科学领域:
- 卫生经济学 卫生经济学
- 药物安全 药物安全
- 医疗保健管理的管理
背景情况:
- 药物错误对医疗保健系统构成了重大但未定量的负担.
- 目前缺乏标准化的方法和药物错误的成本变量列表.
- 这项研究解决了对斯里兰卡药物错误的提供者角度成本分析的需求.
研究的目的:
- 为计算药物错误成本建立一个标准的成本变量清单 (SLCV).
- 为利用这些成本变量制定指导方针.
- 评估斯里兰卡医疗保健机构中确定成本变量的可访问性和可衡量性.
主要方法:
- 一项系统性审查确定了药物错误的全球成本变量.
- 18名专家参与的Delphi研究评估了这些变量的适当性,准确性,可访问性和可衡量性.
- 医院账单分析评估了所选成本变量的实际可访问性和可衡量性.
主要成果:
- 在Delphi Round 1中,13个初始成本变量中有9个被认为是适当的,但没有一个是可访问或可测量的.
- 制定了一项指导方针,导致在Delphi第2轮中保留了八个变量的SLCV.
- 医院账单分析证实了开发的SLCV中大多数变量的可访问性和可测量性.
结论:
- 为斯里兰卡制定了一个由八个变量组成的验证的SLCV和附带的指南.
- 该研究成功地建立了一个框架,从提供者的角度来看,计算药物错误的成本.
- 这些发现为更准确地对该地区的药物错误进行经济评估提供了基础.
相关概念视频
Errors occurring during blood pressure monitoring
1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
Several factors...
1.3K
Systematic Error: Methodological and Sampling Errors
8.9K
In the case of systematic errors, the sources can be identified, and the errors can be subsequently minimized by addressing these sources. According to the source, systematic errors can be divided into sampling, instrumental, methodological, and personal errors.
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
Sampling errors originate from improper sampling methods or the wrong sample population. These errors can be minimized by refining the sampling strategy. Defective instruments or faulty calibrations are the sources of instrumental...
8.9K
Dosage Regimens: Designs and Approaches
261
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
261
Guidelines for Nursing Documentation I
1.8K
Quality documentation and reporting share essential characteristics that ensure they are practical and valuable resources for those who use them. These characteristics are:
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
Factual:
The following points emphasize the significance of upholding accurate and unbiased documentation in healthcare.
1.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Dosage Regimen: Individualization
166
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
166


